Entering text into the input field will update the search result below

Covetrus gains on buyout offer from CD&R and TPG

May 20, 2022 8:32 AM ETCovetrus, Inc. (CVET) StockBy: Dulan Lokuwithana, SA News Editor6 Comments

Success business chart with green arrow up and USA dollars background. Profit and money. Financial and business graph. Stock market growth 3d illustration.

JuSun/iStock via Getty Images

  • Animal health company, Covetrus, Inc. (NASDAQ:CVET) has added ~14% in the pre-market Friday after disclosing that Clayton, Dubilier & Rice, LLC, and TPG offered to buy all of the outstanding shares of its common stock for $21.00 per share

Recommended For You

Comments (6)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

I imagine acquirer can vote their own, currently owned shares to approve, but I am not sure. Also, I think rules may differ in say Netherlands. Anyone know?
Wuffy profile picture
Management missteps have caused this company to crater. Be lucky you get 21 if that’s the final offer.
simonf profile picture
$21 way too low ….. no value assigned to the potential of the business over the next few years as new strategy gains traction. Happy to turn down offer and take my chances that the share price will be materially higher in a few years.
so as someone with some fair amount of shares, what does this mean exactly?
mike ekim profile picture
@orange_tree you get $21 a share for your shares...brokerage co. will credit your acct when the deal closes...i don't own the stock though
Need way more than $21/sh for my shares. Animal healthcare companies should be trading at a premium. This price is not even close to the 52 week high.

Related Stocks

SymbolLast Price% Chg
Covetrus, Inc.
Charles & Colvard, Ltd.
Arcadis NV
Virbac SA
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.